During the Dutch Longdagen 2016, Dr. Loes Kistemaker, research group Molecular Pharmacology of the Groningen Research Institute of Pharmacy (GRIP), was awarded the NRS Swieringa Thesis Award. Loes Kistemaker received the award together with a price of € 4.500,-. The Swieringa Thesis Awarded is granted annually to the best thesis in the field of lung diseases, diagnostics and therapy.
obtained her PhD
in March 2015 and was rewarded the classification cum laude.
She graduated under the supervision of Prof. R. Gosens, Prof. H. Meurs (GRIP) and
Prof. H. Kerstjens (UMCG).
The studies Loes Kistemaker described in her thesis have revealed that acetylcholine contributes to airway
inflammation and remodeling in asthma and Chronic Obstructive Pulmonary Disease (COPD) specifically via M3 muscarinic receptors. In addition, she provided the first evidence that inflammation in COPD is in part mediated by the neurotransmitter acetylcholine. This suggests that patients with asthma or COPD might benefit from M3-selective antagonists to a much larger extent than previously appreciated.
The ENLIGHT consortium of nine European universities, including the University of Groningen, was selected within the framework of the second call for ‘European Universities’, the European Commission's pilot program for new multilateral networks....
Aan het einde van de zomer komen er naast veel Nederlandse studenten ook internationale studenten naar Groningen om voor kortere of langere tijd te studeren aan de Hanzehogeschool Groningen (HG) of de Rijksuniversiteit Groningen (RUG). Vanwege de...
Lung doctor Sander de Hosson has been elected Alumnus of the Year 2019 by the University of Groningen. He is receiving the award for the incisive way in which he calls for attention for the emotional side of palliative care and for making death a...